Newlink Genetics (NLNK) Posts Q2 Loss of 33c/Share

Newlink Genetics (NASDAQ: NLNK) reported Q2 EPS of ($0.33), $0.09 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $212 thousand versus the consensus estimate of $290 thousand.

For earnings history and earnings-related data on Newlink Genetics (NLNK) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
• UBS Reiterates Buy Rating on Sysco (SYY) Following Trip to Company Headquarters